Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Study to Evaluate Vectical in Combination With Clobex Spray to Treatment Plaque Psoriasis [Phase 4]
This document reports the completion of a Phase 4 clinical trial evaluating the combination of Vectical (calcipotriene) and Clobex spray (cl…
-
CLINICAL_TRIALS trial_result · 2010-09-02Clinical Trial Update: Raptiva in Palm and Sole Psoriasis [Phase 4]
Phase 4 study of Raptiva (efalizumab) for palm and sole involvement in chronic plaque psoriasis was terminated, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-08-30Clinical Trial Update: Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis [Phase 4]
A Phase 4 clinical trial evaluating the effects of etanercept on nail psoriasis and plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2010-08-30Clinical Trial Update: TRUST Study: Raptiva ® in Hand & Foot Psoriasis [Phase 4]
Phase 4 trial update for Raptiva (efalizumab) in hand and foot psoriasis shows the study was terminated. Results were posted on 2010-08-30.
-
CLINICAL_TRIALS trial_result · 2010-08-30Clinical Trial Update: ChangE From Any Systemic psoriasiS therapY to Raptiva [Phase 4]
Phase 4 trial evaluating switching chronic plaque psoriasis patients from any systemic therapy to Raptiva (efalizumab); the study was termin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-08-24Clinical Trial Update: Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept [Phase 3]
Phase 3 trial evaluating safety and efficacy of adalimumab in plaque psoriasis patients who did not have an adequate response to etanercept.
-
FDA approval · 2010-07-29FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA has approved a supplemental application for HUMIRA (adalimumab) filed by Cordavis Limited.
-
FDA approval · 2010-07-29FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for CIMZIA (certolizumab pegol) submitted by UCB, Inc., resulting in an approved amendment to it…
-
FDA approval · 2010-06-03FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for Enbrel (etanercept) submitted by Immunex Corporation.
-
FDA approval · 2010-03-30FDA Approved: CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application by Prasco Laboratories to market a Calcipotriene and Betamethrone Dipropionate product for treating …
-
FDA approval · 2010-03-24FDA Approved: CALCIPOTRIENE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's CALCIPOTRIENE original ANDA, granting a generic version of the topical psoriasis treatment.
-
CLINICAL_TRIALS trial_result · 2010-03-09Clinical Trial Update: A Study to Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528) [Phase 2]
This Phase 2 trial evaluates infliximab (Remicade) for moderate-to-severe chronic plaque psoriasis in a Middle Eastern population. The study…
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment [Phase 3]
Phase 3 trial evaluating adalimumab in combination with a calcipotriol/betamethasone dipropionate topical treatment for moderate-to-severe c…
-
FDA approval · 2009-12-30FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2009-11-13Clinical Trial Update: ACT-128800 in Psoriasis [Phase 2]
Actelion reported the completion of a Phase 2 trial of ACT-128800 in plaque psoriasis.
-
FDA approval · 2009-09-25FDA Approved: USTEKINUMAB — Original Application (Janssen Biotech, Inc.)
The FDA approved ustekinumab (Stelara) from Janssen Biotech as the original approval for adults with moderate to severe plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2009-08-20Clinical Trial Update: Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis [Phase 4]
Phase 4 trial comparing clobetasol propionate spray versus ointment in plaque psoriasis; results posted.
-
CLINICAL_TRIALS trial_result · 2009-06-05Clinical Trial Update: A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent [Phase 4]
This document reports a Phase 4 clinical trial evaluating Raptiva (efalizumab) in adults with chronic moderate to severe plaque psoriasis wh…
-
CLINICAL_TRIALS trial_result · 2009-04-10Clinical Trial Update: Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab [Phase 4]
A Phase 4 study evaluated treatment of mild-to-moderate joint pain in patients with chronic plaque psoriasis who are receiving efalizumab. T…
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis [Phase 2]
Clinical trial update noting the completion of a Phase 2 study of MEDI-522 administered subcutaneously to adults with plaque psoriasis. The …
-
FDA approval · 2009-03-20FDA Approved: TACLONEX — Supplemental Application (LEO Pharma Inc.)
The FDA approved a supplemental application for Taclonex (calcipotriene and betamethasone dipropionate) from LEO Pharma Inc., updating its l…
-
CLINICAL_TRIALS trial_result · 2009-01-15Clinical Trial Update: A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis [Phase 2]
Phase 2 exploratory trial completed evaluating the activity of CRx-197-002 in plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2008-11-20Clinical Trial Update: Safety and Tolerability of Repeat Courses of IM Alefacept [Phase 4]
This Phase 4 clinical trial update reports safety and tolerability data for repeat courses of IM alefacept in chronic plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2008-11-19Clinical Trial Update: LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis [NA]
A completed clinical trial comparing LCD Solution with Calcipotriol Cream for chronic plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2008-09-25Clinical Trial Update: Study of CRx-191 to Assess Activity in Plaque Psoriasis [Phase 2]
A Phase 2 trial of CRx-191 in plaque psoriasis has completed, with activity assessed; detailed results are not provided in the snippet.